Brean Capital Says VRTX Buy Opportunity. $ 69 Target. LINK
Vertex should be bought on weakness, says Brean Capital at Brean Capital
fly on the wall – 52 minutes ago
Brean Capital said investors should be opportunistic buyers on any weakness in Vertex shares following its disappointing financial results. The firm said the share price does not reflect the value of the company's cystic fibrosis franchise. Shares remain Buy rated with a $69 price target.